90 related articles for article (PubMed ID: 1903260)
1. HIV-1 indicator cell lines.
Akrigg A; Wilkinson GW; Angliss S; Greenaway PJ
AIDS; 1991 Feb; 5(2):153-8. PubMed ID: 1903260
[TBL] [Abstract][Full Text] [Related]
2. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.
Kimpton J; Emerman M
J Virol; 1992 Apr; 66(4):2232-9. PubMed ID: 1548759
[TBL] [Abstract][Full Text] [Related]
3. Direct detection of infectious HIV-1 in blood using a centrifugation-indicator cell assay.
Harrington R; Wu L; Pullen H; Emerman M
J Virol Methods; 2000 Jul; 88(1):111-5. PubMed ID: 10921848
[TBL] [Abstract][Full Text] [Related]
4. Abortive infection in HeLaCD4 cells by a primary HIV type 1 isolate: implications for differential host cell tropism.
Smyth RJ; Yi Y; Kim FM; Collman RG
AIDS Res Hum Retroviruses; 1997 Jun; 13(9):759-69. PubMed ID: 9171220
[TBL] [Abstract][Full Text] [Related]
5. [A non-infectious and quantitative cell-based bioassay for screening HIV entry inhibitors targeting HIV envelope proteins].
Li MM; Xia CL; Mao QC; Jiang SB; Liu SW
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):941-4. PubMed ID: 20501362
[TBL] [Abstract][Full Text] [Related]
6. A microassay for determination of the cytopathogenicity of human immunodeficiency virus type-1 isolates.
Benyoucef S; Hober D; Shen L; Ajana F; Gérard Y; Bocket-Mouton L; Mouton Y; Wattré P
Microbiol Immunol; 1996; 40(5):381-8. PubMed ID: 8805103
[TBL] [Abstract][Full Text] [Related]
7. Protection of HeLa-T4+ cells against human immunodeficiency virus (HIV) infection after stable transfection with HIV LTR-2',5'-oligoadenylate synthetase hybrid gene.
Schröder HC; Ugarkovic D; Merz H; Kuchino Y; Okamoto T; Müller WE
FASEB J; 1990 Oct; 4(13):3124-30. PubMed ID: 1698680
[TBL] [Abstract][Full Text] [Related]
8. Activation of a beta-galactosidase recombinant provirus: application to titration of human immunodeficiency virus (HIV) and HIV-infected cells.
Rocancourt D; Bonnerot C; Jouin H; Emerman M; Nicolas JF
J Virol; 1990 Jun; 64(6):2660-8. PubMed ID: 2110596
[TBL] [Abstract][Full Text] [Related]
9. Development and automation of a 384-well cell fusion assay to identify inhibitors of CCR5/CD4-mediated HIV virus entry.
Bradley J; Gill J; Bertelli F; Letafat S; Corbau R; Hayter P; Harrison P; Tee A; Keighley W; Perros M; Ciaramella G; Sewing A; Williams C
J Biomol Screen; 2004 Sep; 9(6):516-24. PubMed ID: 15452338
[TBL] [Abstract][Full Text] [Related]
10. Histochemical staining of clonal mammalian cell lines expressing E. coli beta galactosidase indicates heterogeneous expression of the bacterial gene.
MacGregor GR; Mogg AE; Burke JF; Caskey CT
Somat Cell Mol Genet; 1987 May; 13(3):253-65. PubMed ID: 2440117
[TBL] [Abstract][Full Text] [Related]
11. A computer-based, image-analysis method to quantify HIV-1 infection in a single-cycle infectious center assay.
Day JR; Martínez LE; Sásik R; Hitchin DL; Dueck ME; Richman DD; Guatelli JC
J Virol Methods; 2006 Oct; 137(1):125-33. PubMed ID: 16876264
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates.
Chackerian B; Haigwood NL; Overbaugh J
Virology; 1995 Nov; 213(2):386-94. PubMed ID: 7491763
[TBL] [Abstract][Full Text] [Related]
13. Syncytium induction by fresh HIV isolates: quantitative analysis using a transactivation beta-gal assay.
Emilie D; Maillot MC; Bonnerot C; Devergne O; Delfraissy JF; Nicolas JF; Galanaud P
AIDS; 1990 Aug; 4(8):791-7. PubMed ID: 1979746
[TBL] [Abstract][Full Text] [Related]
14. A sensitive method for the detection of beta-galactosidase in transfected mammalian cells.
Eustice DC; Feldman PA; Colberg-Poley AM; Buckery RM; Neubauer RH
Biotechniques; 1991 Dec; 11(6):739-40, 742-3. PubMed ID: 1809326
[TBL] [Abstract][Full Text] [Related]
15. Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection.
Gibellini D; Caputo A; Celeghini C; Bassini A; La Placa M; Capitani S; Zauli G
Br J Haematol; 1995 Jan; 89(1):24-33. PubMed ID: 7530479
[TBL] [Abstract][Full Text] [Related]
16. Rev-binding aptamer and CMV promoter act as decoys to inhibit HIV replication.
Konopka K; Lee NS; Rossi J; Düzgüneş N
Gene; 2000 Sep; 255(2):235-44. PubMed ID: 11024283
[TBL] [Abstract][Full Text] [Related]
17. Attenuated and wild-type HIV-1 infections and long terminal repeat-mediated gene expression from plasmids delivered by gene gun to human skin ex vivo and macaques in vivo.
Kent SJ; Cameron PU; Reece JC; Thompson PR; Purcell DF
Virology; 2001 Aug; 287(1):71-8. PubMed ID: 11504543
[TBL] [Abstract][Full Text] [Related]
18. Alternatives to X-galactopyranoside in screening recombinant clones based on pUC-derived plasmid vectors.
Karlovsky P
Methods Enzymol; 1993; 217():335-9. PubMed ID: 8474339
[No Abstract] [Full Text] [Related]
19. A bioassay for HIV-1 based on Env-CD4 interaction.
Ciminale V; Felber BK; Campbell M; Pavlakis GN
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1281-7. PubMed ID: 2078409
[TBL] [Abstract][Full Text] [Related]
20. A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosidase.
Lim K; Chae CB
Biotechniques; 1989 Jun; 7(6):576-9. PubMed ID: 2517211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
